Advanced Search
EurekAlert! Science News A service of the American Association for the Advancement of Science
EurekAlert! Science News A service of the American Association for the Advancement of Science
  • Home
  • News Releases
  • Multimedia
  • Meetings
  • Login
  • Register

RedHill Biopharma (IMAGE)

RedHill Biopharma

RedHill Biopharma

Caption

RedHill Biopharma

Credit

RedHill Biopharma

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Media Contact

Rob Cohen
RedHill Biopharma
rob@redhillbio.com
Office: 54-888-6095



More on this News Release

RedHill Biopharma announces positive new data with Opaganib for nuclear radiation injury

RedHill Biopharma

Tags

  • /Physical sciences/Physics/Energy/Radiation/Ionizing radiation/Nuclear radiation
  • /Health and medicine/Clinical medicine/Medical treatments/Drug therapy
  • /Health and medicine/Clinical medicine/Medical treatments/Cancer treatments/Radiation therapy
  • /Health and medicine/Medical specialties/Hematology
  • /Life sciences/Organismal biology/Anatomy/Kidney
  • /Physical sciences/Physics/Particle physics/Nuclear physics/Nuclear reactions/Radioactivity/Irradiation
  • /Life sciences/Biochemistry/Biomolecules/Enzyme inhibitors/Kinase inhibitors
  • /Life sciences/Biochemistry/Toxicology/Toxicity/Renal toxicity
  • /Applied sciences and engineering/Engineering/Bioengineering/Biotechnology

Original Source

https://www.redhillbio.com/news/news-details/2022/RedHill-Biopharma-Announces-Positive-New-Data-with-Opaganib-for-Nuclear-Radiation-Injury/default.aspx

EurekAlert! The Global Source for Science News

AAAS - American Association for the Advancement of Science

Copyright © 2026 by the American Association for the Advancement of Science (AAAS)

  • facebook.com/EurekAlert
  • @EurekAlert
  • youtube.com/EurekAlert

  • Help / FAQ
  • Services
  • Eligibility Guidelines
  • Contact EurekAlert!
  • Terms & Conditions
  • DMCA
  • Privacy Policy
  • Disclaimer

Copyright © 2026 by the American Association for the Advancement of Science (AAAS)